002099 海翔药业
已收盘 08-25 15:00:00
资讯
新帖
简况
股市必读：海翔药业(002099)股东户数3.18万户，较上期减少7%
证券之星 · 08-12
股市必读：海翔药业(002099)股东户数3.18万户，较上期减少7%
海翔药业：公司综合施策，致力于提升经营质量，不断夯实基本面
证券之星 · 08-11
海翔药业：公司综合施策，致力于提升经营质量，不断夯实基本面
海翔药业：截至8月10日公司股东人数为31837人
证券之星 · 08-11
海翔药业：截至8月10日公司股东人数为31837人
股市必读：海翔药业（002099）8月5日董秘有最新回复
证券之星 · 08-06
股市必读：海翔药业（002099）8月5日董秘有最新回复
海翔药业：公司目前不存在任何触及退市风险的情形
证券之星 · 08-05
海翔药业：公司目前不存在任何触及退市风险的情形
股市必读：海翔药业新发布《关于股份回购进展情况的公告》
证券之星 · 08-05
股市必读：海翔药业新发布《关于股份回购进展情况的公告》
海翔药业（002099）披露股份回购进展公告，8月3日股价上涨1.1%
证券之星 · 08-03
海翔药业（002099）披露股份回购进展公告，8月3日股价上涨1.1%
股市必读：海翔药业新发布《关于全资子公司换发《兽药生产许可证》和《兽药GMP证书》的公告》
证券之星 · 08-03
股市必读：海翔药业新发布《关于全资子公司换发《兽药生产许可证》和《兽药GMP证书》的公告》
海翔药业（002099）披露全资子公司换发《兽药生产许可证》和《兽药GMP证书》公告，7月30日股价下跌0.73%
证券之星 · 07-30
海翔药业（002099）披露全资子公司换发《兽药生产许可证》和《兽药GMP证书》公告，7月30日股价下跌0.73%
海翔药业：目前双方合作正常开展
证券之星 · 07-27
海翔药业：目前双方合作正常开展
股市必读：海翔药业（002099）7月21日董秘有最新回复
证券之星 · 07-22
股市必读：海翔药业（002099）7月21日董秘有最新回复
海翔药业：后续公司立足主业，聚焦市场需求，致力于提升经营质量，不断夯实基本面价值
证券之星 · 07-21
海翔药业：后续公司立足主业，聚焦市场需求，致力于提升经营质量，不断夯实基本面价值
海翔药业：双方目前常态化、机制化地就新工艺、新产品进行交流
证券之星 · 07-21
海翔药业：双方目前常态化、机制化地就新工艺、新产品进行交流
海翔药业（002099）披露回购股份数超过总股本1%的公告，7月20日股价上涨1.2%
证券之星 · 07-20
海翔药业（002099）披露回购股份数超过总股本1%的公告，7月20日股价上涨1.2%
股市必读：海翔药业（002099）7月10日董秘有最新回复
证券之星 · 07-13
股市必读：海翔药业（002099）7月10日董秘有最新回复
股市必读：海翔药业（002099）7月8日董秘有最新回复
证券之星 · 07-09
股市必读：海翔药业（002099）7月8日董秘有最新回复
海翔药业（002099）披露股份回购进展公告，7月1日股价上涨2.84%
证券之星 · 07-01
海翔药业（002099）披露股份回购进展公告，7月1日股价上涨2.84%
海翔药业：公司已于2026年6月25日开展首次回购
证券之星 · 06-30
海翔药业：公司已于2026年6月25日开展首次回购
海翔药业（002099）披露首次回购公司股份公告，6月26日股价下跌3.53%
证券之星 · 06-26
海翔药业（002099）披露首次回购公司股份公告，6月26日股价下跌3.53%
海翔药业（002099）披露回购股份事项前十名股东持股情况，6月24日股价下跌3.01%
证券之星 · 06-24
海翔药业（002099）披露回购股份事项前十名股东持股情况，6月24日股价下跌3.01%
加载更多
公司概况
公司名称：
浙江海翔药业股份有限公司
所属行业：
医药制造业
上市日期：
2006-12-26
主营业务：
浙江海翔药业股份有限公司的主营业务是原料药及医药中间体、染料及染颜料中间体的研发、生产和销售。公司的主要产品是蒽醌系列染料产品、中间体。公司企业技术中心被认定为“国家级企业技术中心”，拥有国家级博士后工作站，已承担完成国家级项目14项，省级项目35项，拥有国内发明专利67项、PCT专利4项，荣获浙江省级科技奖项11项。
发行价格：
11.56
{"stockData":{"symbol":"002099","market":"SZ","secType":"STK","nameCN":"海翔药业","latestPrice":5.19,"timestamp":1787641407000,"preClose":5.05,"halted":0,"volume":12307718,"delay":0,"changeRate":0.0277,"floatShares":1617000000,"shares":1619000000,"eps":-0.0457,"marketStatus":"已收盘","change":0.14,"latestTime":"08-25 15:00:00","open":5.06,"high":5.2,"low":5.02,"amount":63233700,"amplitude":0.0356,"askPrice":5.19,"askSize":272,"bidPrice":5.18,"bidSize":571,"shortable":0,"etf":0,"ttmEps":-0.0457,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.05,"symbolType":"stock","openAndCloseTimeList":[[1787621400000,1787628600000],[1787634000000,1787641200000]],"highLimit":5.56,"lowLimit":4.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1618715253,"isCdr":false,"pbRate":1.65,"roa":"--","roe":"0.53%","epsLYR":-0.06,"committee":-0.482272,"marketValue":8401000000,"turnoverRate":0.0076,"status":0,"floatMarketCap":8391000000},"requestUrl":"/m/hq/s/002099","defaultTab":"news","newsList":[{"id":"2658917632","title":"股市必读：海翔药业(002099)股东户数3.18万户，较上期减少7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658917632","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658917632?lang=zh_cn&edition=full","pubTime":"2026-08-12 02:07","pubTimestamp":1786471631,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，海翔药业报收于5.41元，下跌0.18%，换手率0.6%，成交量9.73万手，成交额5289.23万元。股本股东变化股东户数变动截至2026年8月10日公司股东户数为3.18万户，较6月18日减少2396.0户，减幅为7.0%。投资者： 尊敬的董秘您好，请问公司八月十日的股东人数，谢谢董秘： 您好，截至8月10日公司股东人数为31837人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200002055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002099","BK0077","BK0239","BK0192","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996006","title":"海翔药业：公司综合施策，致力于提升经营质量，不断夯实基本面","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996006","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996006?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:36","pubTimestamp":1786433795,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，公司董秘每次对关键问题都避而不谈，针对这种情况如果改善？公司连续巨亏如何向投资者交代？请详细回答，谢谢。海翔药业回复：您好，公司综合施策，致力于提升经营质量，不断夯实基本面。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100019909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0239","BK0192","BK0077","002099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658960704","title":"海翔药业：截至8月10日公司股东人数为31837人","url":"https://stock-news.laohu8.com/highlight/detail?id=2658960704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658960704?lang=zh_cn&edition=full","pubTime":"2026-08-11 15:34","pubTimestamp":1786433667,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好，请问公司八月十日的股东人数，谢谢海翔药业回复：您好，截至8月10日公司股东人数为31837人。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100019582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002099","BK0028","BK0239","BK0188","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657216445","title":"股市必读：海翔药业（002099）8月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657216445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657216445?lang=zh_cn&edition=full","pubTime":"2026-08-06 01:32","pubTimestamp":1785951133,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，海翔药业报收于5.41元，下跌1.46%，换手率0.6%，成交量9.73万手，成交额5292.2万元。董秘最新回复投资者： 你好，针对公司主业医药方面连续亏损的现状，公司是否有退市风险？请详细说明，谢谢。当日关注点交易信息汇总：8月5日主力资金净流出621.19万元，占总成交额11.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001494.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0188","BK0192","BK0028","BK0239","002099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657083542","title":"海翔药业：公司目前不存在任何触及退市风险的情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2657083542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657083542?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:52","pubTimestamp":1785934334,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)08月05日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，针对公司主业医药方面连续亏损的现状，公司是否有退市风险？谢谢。海翔药业回复：您好，根据《深圳证券交易所股票上市规则》，公司目前不存在任何触及退市风险的情形。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500041343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0077","002099","BK0188","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657206563","title":"股市必读：海翔药业新发布《关于股份回购进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657206563","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657206563?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:09","pubTimestamp":1785866951,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，海翔药业报收于5.49元，下跌0.36%，换手率0.59%，成交量9.54万手，成交额5258.72万元。当日关注点交易信息汇总：8月4日主力资金净流出383.31万元，占总成交额7.29%。公司公告汇总：截至2026年7月31日，海翔药业已回购股份24,161,073股，占总股本1.49%，成交总金额1.228亿元，回购进展符合既定方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001966.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0192","BK0188","BK0028","002099","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656377236","title":"海翔药业（002099）披露股份回购进展公告，8月3日股价上涨1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656377236","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656377236?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:36","pubTimestamp":1785767782,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，海翔药业报收于5.51元，较前一交易日上涨1.1%，最新总市值为89.19亿元。该股当日开盘5.47元，最高5.52元，最低5.41元，成交额达4629.5万元，换手率为0.52%。近日，海翔药业发布《关于股份回购进展情况的公告》。公告显示，公司于2026年6月22日召开董事会，审议通过回购股份方案，拟使用自有/自筹资金以集中竞价交易方式回购公司股份，用于未来股权激励或员工持股计划。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300037603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0239","002099","BK0028","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343266","title":"股市必读：海翔药业新发布《关于全资子公司换发《兽药生产许可证》和《兽药GMP证书》的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343266","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343266?lang=zh_cn&edition=full","pubTime":"2026-08-03 03:32","pubTimestamp":1785699134,"startTime":"0","endTime":"0","summary":"公司公告汇总关于全资子公司换发《兽药生产许可证》和《兽药GMP证书》的公告浙江海翔药业股份有限公司全资子公司浙江海翔川南药业有限公司近日收到浙江省农业农村厅换发的《兽药生产许可证》和《兽药GMP证书》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002099","BK0028","BK0192","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655805273","title":"海翔药业（002099）披露全资子公司换发《兽药生产许可证》和《兽药GMP证书》公告，7月30日股价下跌0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655805273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655805273?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:20","pubTimestamp":1785421236,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，海翔药业报收于5.43元，较前一交易日下跌0.73%，最新总市值为87.9亿元。该股当日开盘5.41元，最高5.5元，最低5.35元，成交额达8834.05万元，换手率为1.01%。近日，浙江海翔药业股份有限公司全资子公司浙江海翔川南药业有限公司收到浙江省农业农村厅换发的《兽药生产许可证》和《兽药GMP证书》。证书显示，生产范围为非无菌原料药，有效期至2027年5月17日。但药品生产销售受政策和市场环境影响，存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000039705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0239","002099","BK0028","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654209080","title":"海翔药业：目前双方合作正常开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2654209080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654209080?lang=zh_cn&edition=full","pubTime":"2026-07-27 15:27","pubTimestamp":1785137227,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)07月27日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，万邦德面临退市风险，贵司和万邦德的合作目前的进展？如果万邦德退市，贵司的预付款是否可以追回？针对万邦德退市风险贵司的应对措施？谢谢。海翔药业回复：您好，根据双方签订的《创新药合作协议》：万邦德以自有团队和资源，具体实施WP205产品研发、上市、授权、销售等各项工作。公司按照约定提供资金并取得相关收益权。目前双方合作正常开展。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700013836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002099","BK0192","BK0028","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653202089","title":"股市必读：海翔药业（002099）7月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653202089","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653202089?lang=zh_cn&edition=full","pubTime":"2026-07-22 02:09","pubTimestamp":1784657386,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，海翔药业报收于5.01元，下跌0.99%，换手率1.31%，成交量21.23万手，成交额1.05亿元。公司公告汇总：截至7月17日，海翔药业已回购股份16,281,073股，占总股本1.01%，成交金额83,281,256.73元，回购进展符合方案要求。公司公告汇总关于回购股份数超过总股本1%的公告浙江海翔药业股份有限公司于2026年6月22日召开第八届董事会第四次会议，审议通过回购股份方案，拟使用自有/自筹资金以集中竞价交易方式回购公司股份，用于股权激励或员工持股计划。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200002654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0192","BK0239","002099","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653940270","title":"海翔药业：后续公司立足主业，聚焦市场需求，致力于提升经营质量，不断夯实基本面价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2653940270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653940270?lang=zh_cn&edition=full","pubTime":"2026-07-21 20:52","pubTimestamp":1784638372,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业07月21日在投资者关系平台上答复投资者关心的问题。二级市场股价波动受多种因素影响，与公司基本面、宏观环境、政策因素、行业状况及资本市场风格等多重因素密切相关。公司回购股票是市值管理的重要手段之一。后续公司立足主业，聚焦市场需求，致力于提升经营质量，不断夯实基本面价值。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100042383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002099","BK0188","BK0077","BK0239","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653820223","title":"海翔药业：双方目前常态化、机制化地就新工艺、新产品进行交流","url":"https://stock-news.laohu8.com/highlight/detail?id=2653820223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653820223?lang=zh_cn&edition=full","pubTime":"2026-07-21 11:37","pubTimestamp":1784605059,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业(002099)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘：您好！公司2025年12月与国科大杭州高等研究院签署五年期产业研究院合作协议，聚焦染料、芳香胺绿色合成技术，目前项目研发进度如何？相关新工艺预计何时导入公司现有产线？烦请董秘解答告知，感谢！海翔药业回复：双方目前常态化、机制化地就新工艺、新产品进行交流，探索产业化落地的机会。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100018768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0192","002099","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652214589","title":"海翔药业（002099）披露回购股份数超过总股本1%的公告，7月20日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652214589","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652214589?lang=zh_cn&edition=full","pubTime":"2026-07-20 22:47","pubTimestamp":1784558830,"startTime":"0","endTime":"0","summary":"截至2026年7月20日收盘，海翔药业报收于5.06元，较前一交易日上涨1.2%，最新总市值为81.91亿元。该股当日开盘4.95元，最高5.07元，最低4.89元，成交额达1.19亿元，换手率为1.48%。近日，海翔药业发布《关于回购股份数超过总股本1%的公告》。截至2026年7月17日，公司已回购股份16,281,073股，占总股本的1.01%，最高成交价5.44元/股，最低成交价4.93元/股，成交总金额83,281,256.73元。回购行为符合相关法规及既定方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000040042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002099","BK0028","BK0192","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651165780","title":"股市必读：海翔药业（002099）7月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651165780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651165780?lang=zh_cn&edition=full","pubTime":"2026-07-13 01:32","pubTimestamp":1783877531,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，海翔药业报收于5.24元，上涨2.34%，换手率1.52%，成交量24.55万手，成交额1.29亿元。董秘最新回复投资者： 公司一方面布局CDMO新药研发业务，另一方面通过产业基金参股了天兵航天等商业航天企业。交易信息汇总资金流向7月10日主力资金净流出884.28万元，占总成交额0.0%；游资资金净流出9.5万元；散户资金净流入893.78万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300000784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002099","BK0028","BK0192","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650199002","title":"股市必读：海翔药业（002099）7月8日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2650199002","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650199002?lang=zh_cn&edition=full","pubTime":"2026-07-09 01:31","pubTimestamp":1783531868,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，海翔药业报收于5.15元，下跌2.09%，换手率0.96%，成交量15.51万手，成交额8026.64万元。董秘最新回复投资者： 尊敬的董秘您好，请问公司六月底的股东人数，谢谢董秘： 您好，公司六月底股东人数请关注公司后续披露的《2026年半年度报告》。交易信息汇总资金流向7月8日主力资金净流出796.48万元，占总成交额0.0%；游资资金净流入44.14万元，占总成交额0.0%；散户资金净流入752.33万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900001373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0192","BK0077","BK0028","002099","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648541606","title":"海翔药业（002099）披露股份回购进展公告，7月1日股价上涨2.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648541606","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648541606?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:36","pubTimestamp":1782916574,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，海翔药业报收于5.43元，较前一交易日上涨2.84%，最新总市值为87.9亿元。该股当日开盘5.25元，最高5.6元，最低5.15元，成交额达1.58亿元，换手率为1.83%。近日，浙江海翔药业股份有限公司披露《关于股份回购进展情况的公告》。公告显示，公司于2026年6月22日召开董事会，审议通过回购股份方案，拟使用自有/自筹资金以集中竞价交易方式回购公司股份，用于未来股权激励或员工持股计划。回购进展符合相关法规及既定方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0192","002099","BK0188","BK0239","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647794556","title":"海翔药业：公司已于2026年6月25日开展首次回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2647794556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647794556?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:53","pubTimestamp":1782823988,"startTime":"0","endTime":"0","summary":"证券之星消息，海翔药业06月30日在投资者关系平台上答复投资者关心的问题。贵公司是否存在炒自家股票，低买高卖等行为？海翔药业回复：您好，公司已于2026年6月25日开展首次回购，内容详见《关于首次回购公司股份的公告》。在实际操作中，公司将综合考虑股价表现、资金安排及市场环境等因素，审慎把握回购时机，稳步推进回购工作，切实维护公司价值与全体股东合法权益。感谢您对公司的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000043958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0239","002099","BK0028","BK0192"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646551513","title":"海翔药业（002099）披露首次回购公司股份公告，6月26日股价下跌3.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646551513","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646551513?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:50","pubTimestamp":1782467459,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，海翔药业报收于5.19元，较前一交易日下跌3.53%，最新总市值为84.01亿元。该股当日开盘5.37元，最高5.45元，最低5.04元，成交额达1.62亿元，换手率为1.93%。公司于近日披露《关于首次回购公司股份的公告》。本次回购符合相关法律法规及公司董事会审议通过的回购方案。公司后续将在回购期限内根据市场情况继续实施回购计划，并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0192","002099","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645819709","title":"海翔药业（002099）披露回购股份事项前十名股东持股情况，6月24日股价下跌3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645819709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645819709?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:30","pubTimestamp":1782311432,"startTime":"0","endTime":"0","summary":"截至2026年6月24日收盘，海翔药业报收于5.16元，较前一交易日下跌3.01%，最新总市值为83.53亿元。该股当日开盘5.37元，最高5.38元，最低5.16元，成交额达1.03亿元，换手率为1.22%。近日，浙江海翔药业股份有限公司发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》。其中，浙江东港实业有限公司持股523,982,587股，占总股本32.37%；公司回购专用证券账户持有54,212,531股，占总股本3.35%，未列入前十名股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400044081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","BK0239","002099","BK0192","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787699658079,"stockEarnings":[{"period":"1week","weight":-0.0371},{"period":"1month","weight":0.0318},{"period":"3month","weight":-0.0299},{"period":"6month","weight":-0.4122},{"period":"1year","weight":-0.1407},{"period":"ytd","weight":-0.1683}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0197},{"period":"3month","weight":-0.0499},{"period":"6month","weight":-0.062},{"period":"1year","weight":0.0015},{"period":"ytd","weight":-0.02}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海翔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"31837人(较上一季度减少82.49%)","perCapita":"50785股","listingDate":"2006-12-26","address":"浙江省台州市椒江区外沙支路100号","registeredCapital":"161871万元","survey":" 浙江海翔药业股份有限公司的主营业务是原料药及医药中间体、染料及染颜料中间体的研发、生产和销售。公司的主要产品是蒽醌系列染料产品、中间体。公司企业技术中心被认定为“国家级企业技术中心”，拥有国家级博士后工作站，已承担完成国家级项目14项，省级项目35项，拥有国内发明专利67项、PCT专利4项，荣获浙江省级科技奖项11项。","listedPrice":11.56},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海翔药业(002099)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海翔药业(002099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海翔药业,002099,海翔药业股票,海翔药业股票老虎,海翔药业股票老虎国际,海翔药业行情,海翔药业股票行情,海翔药业股价,海翔药业股市,海翔药业股票价格,海翔药业股票交易,海翔药业股票购买,海翔药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海翔药业(002099)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海翔药业(002099)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}